US20070038204A1 - Photoreactive system and methods for prophylactic treatment of atherosclerosis - Google Patents
Photoreactive system and methods for prophylactic treatment of atherosclerosis Download PDFInfo
- Publication number
- US20070038204A1 US20070038204A1 US11/357,358 US35735806A US2007038204A1 US 20070038204 A1 US20070038204 A1 US 20070038204A1 US 35735806 A US35735806 A US 35735806A US 2007038204 A1 US2007038204 A1 US 2007038204A1
- Authority
- US
- United States
- Prior art keywords
- light emitters
- medical apparatus
- emission
- polymer encasement
- encasement portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 37
- 201000001320 Atherosclerosis Diseases 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 229920000642 polymer Polymers 0.000 claims abstract description 159
- 230000005670 electromagnetic radiation Effects 0.000 claims description 36
- 239000012530 fluid Substances 0.000 claims description 36
- 238000005286 illumination Methods 0.000 claims description 21
- 230000008878 coupling Effects 0.000 claims description 18
- 238000010168 coupling process Methods 0.000 claims description 18
- 238000005859 coupling reaction Methods 0.000 claims description 18
- 239000000853 adhesive Substances 0.000 claims description 5
- 230000001070 adhesive effect Effects 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 229920005570 flexible polymer Polymers 0.000 description 15
- 239000000758 substrate Substances 0.000 description 8
- 239000003504 photosensitizing agent Substances 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 238000002428 photodynamic therapy Methods 0.000 description 5
- 230000005284 excitation Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000004913 activation Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 206010012689 Diabetic retinopathy Diseases 0.000 description 2
- 206010064930 age-related macular degeneration Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 208000002780 macular degeneration Diseases 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000005476 soldering Methods 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000771 oncological effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 238000010248 power generation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000002301 subretinal fluid Anatomy 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000006444 vascular growth Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N2005/0602—Apparatus for use inside the body for treatment of blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Electromagnetism (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Medical Informatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
- 1. Field of the Invention
- The present disclosure relates to devices and methods useful in medical diagnostics and treatments, in particular diagnostics and treatments performed in a lumen of a body, for example phototherapeutic treatments that illuminate a portion of the lumen.
- 2. Description of the Related Art
- In recent years, much research has been devoted to phototherapeutic, and especially photoreactive therapies. These therapies typically involve the excitation of a class of photo-reactive compounds (i.e., “photosensitizers”) that kill diseased or undesirable tissue. The photosensitizers are typically activated by illumination with at least one specific wavelength of light (i.e., excitation wavelength) and are used in photodynamic therapy (PDT). Various wavelengths may be suitable depending on the specific photosensitizer, for example wavelengths of electromagnetic radiation in the visible, infrared, and/or ultraviolet portions of the electromagnetic spectrum may be suitable.
- Light sources such as lasers, emitting the appropriate excitation wavelength, are typically used to activate the photosensitizers to treat targeted tissue in a number of eye, cardiac, oncological and other disease conditions. For example, in age related macular degeneration (AMD), glaucoma, and/or diabetic retinopathy (DR), photosensitizers may be used to inhibit formation or retard disease progression such as commonly indicated by rapidly uncontrolled vascular growth (i.e., “neovascularization”) within diseased eye tissue and the associated sub-retinal fluid concentration.
- The two important and related components of a photoreactive treatment system are the photosensitizer and the excitation light source and apparatus for supplying the light appropriately to targeted tissue. Conventional approaches to PDT are challenged by requirements of light exposure of desired intensities, duration, shape, and timing when photosensitizers are present in the diseased tissue. Inaccurately generated illumination, such as misdirected or misshaped illumination, could have unintended affects. Accordingly, an appropriate medical apparatus for providing illumination in a lumen of a body that is well suited to the organ being treated may be a factor in successful treatment.
- Disclosed herein are medical apparatus that employ flexible devices or structures useful in treatment of human subjects with phototherapy, especially photoreactive therapy, whether intraluminal, intravascular or interstitial. These devices each include a plurality of structures that either emit light or contain light emitters, and the structures are arranged adjacent each other to provide a compact device.
- In one embodiment, a medical apparatus useful in illuminating at least a portion of a lumen of a body comprises: an elongated flexible member having a distal end and a proximal end, at least a portion of the elongated flexible member being sized and dimensioned to be received and moved within the lumen of the body; a plurality of light emitters, the light emitters electrically coupled to one another without the use of wire bonds, and operable to emit electromagnetic radiation in at least one characteristic emission waveband; and a polymer encasement portion encasing the plurality of light emitters, at least a portion of the polymer encasement portion being at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband, and the polymer encasement portion being sized and dimensioned to be received and moved within the lumen of the body and positioned proximate the proximal end of the elongated flexible member to be moved in the lumen of the body by movement of the elongated flexible member. The light emitters have a principal axis of emission that may be oriented in two or more different directions. A maximum cross-sectional dimension of the polymer encasement portion may be less than twice a dimension of one of the light emitters measured along the principal axis of emission. The medical apparatus may include an expandable member physically coupled to move in the lumen of the body with the polymer encasement portion, and operable to expand between an expanded configuration and an unexpanded configuration. In some embodiments, the light emitters may be helically arranged.
- In another embodiment, a medical apparatus useful in illuminating at least a portion of a lumen of a body comprises: an elongated flexible member having a distal end and a proximal end, at least a portion of the elongated flexible member being sized and dimensioned to be received and moved within the lumen of the body; a plurality of light emitters each having a principal axis of emission, the light emitters operable to emit electromagnetic radiation in at least one characteristic emission waveband; and a polymer encasement portion encasing the plurality of light emitters, at least a portion of the polymer encasement portion being at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband, the polymer encasement portion having a maximum cross-sectional dimension that is less than two times the sum of a dimension of one of the light emitters measured along the principal axis of emission and a marginal dimension by which an outer portion of the polymer encasement portion extends beyond the light emitter along the principal axis of emission in a direction of principal emission, the polymer encasement portion positioned proximate the proximal end of the elongated flexible member to be moved in the lumen of the body by movement of the elongated flexible member. In some embodiments the polymer encasement portion has a maximum cross-sectional dimension that is less than or equal to the sum of the dimension of one of the light emitters measured along the principal axis of emission and the marginal dimension by which the outer portion of the polymer encasement portion extends beyond the light emitter along the principal axis of emission in the direction of principal emission. In some embodiments, the medical apparatus may include an expandable member physically coupled to move in the lumen of the body with the polymer encasement portion, at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband, and operable to expand between an expanded configuration and an unexpanded configuration. In some embodiments, the light emitters may be helically arranged.
- In another embodiment, a method of forming a medical apparatus useful in illuminating at least a portion of a lumen of a body comprises: electrically coupling a plurality of light emitters without the use of wire bonds, the light emitters operable to emit electromagnetic radiation in at least one characteristic emission waveband; encasing the plurality of light emitters in a polymer encasement portion sized and dimensioned to be received in a lumen of a body, at least a portion of the polymer encasement portion being at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband; and physically coupling the polymer encasement portion to an elongated flexible member sized to be at least partially received in a lumen of a body. The method may further comprise helically distributing the light emitters about the longitudinal axis of the cylindrical polymer encasement portion before encasing the plurality of light emitters in a polymer encasement portion. The method may further comprise arranging the light emitters such that the polymer encasement portion has a maximum cross-sectional dimension that is less than two times the sum of a dimension of one of the light emitters measured along a principal axis of emission and a marginal dimension by which an outer portion of the polymer encasement portion extends beyond the light emitter along the principal axis of emission in a direction of principal emission, before encasing the plurality of light emitters in a polymer encasement portion. The method may further comprise arranging the light emitters such that the polymer encasement portion has a maximum cross-sectional dimension that is less than or equal to a sum of a dimension of one of the light emitters measured along a principal axis of emission and a marginal dimension by which an outer portion of the polymer encasement portion extends beyond the light emitter along the principal axis of emission in a direction of principal emission.
- In yet a further embodiment, a medical apparatus useful in illuminating at least a portion of a lumen of a body comprises: an elongated flexible member having a distal end and a proximal end, at least a portion of the elongated flexible member being sized and dimensioned to be received and moved within the lumen of the body; a plurality of light emitters operable to emit electromagnetic radiation in at least one characteristic emission waveband, wherein the light emitters of the plurality of light emitters are arranged helically with respect to each other about an imaginary longitudinal axis; and a polymer encasement portion encasing the plurality of light emitters, at least a portion of the polymer encasement portion being at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband, the polymer encasement portion positioned proximate the proximal end of the elongated flexible member to be moved in the lumen of the body by movement of the elongated flexible member.
- In still a further embodiment, a method of operating a catheter physically associated with an expandable member and a plurality of light emitters to illuminate a lumen of a body comprises: inflating the expandable member with a fluid medium when the expandable member is positioned in the lumen of the body; providing power to at least some of the plurality of light emitters to provide illumination therefrom when at least some of the plurality of light emitters are positioned in the lumen of the body; and circulating the fluid medium into and out of the expandable member while the expandable member is inflated and during at least a portion of a time when the power is provided to at least some of the plurality of light emitters. Such circulation may be used to advantageously control a temperature in the lumen, for example to transfer heat generated by the light emitters away from the lumen and/or to provide heat to the lumen, for example prior to activation of the light emitters.
- The light emitters may be appropriately spaced apart to allow the polymer encasement portion to flex. The light emitters may be electrically coupleable to a power source for activation either as a total array or as groups of light emitters or light emitter cases, or as individual light emitter cases. In one embodiment, the arrangement permits light to be emitted in opposite directions from the polymer encasement portion.
- In each of the embodiments there are many permutations of structure arrangements possible, and many permutations of electrical activation either as single structures or as groups.
- In the drawings, identical reference numbers identify similar elements or acts. The sizes and relative positions of elements in the drawings are not necessarily drawn to scale. For example, the shapes of various elements and angles are not drawn to scale, and some of these elements are arbitrarily enlarged and positioned to improve drawing legibility. Further, the particular shapes of the elements as drawn are not intended to convey any information regarding the actual shape of the particular elements, and have been solely selected for ease of recognition in the drawings.
-
FIG. 1 is a partial side view of a conventional light emitter structure, employing a number of light emitters that are wire bonded to an electrically conductive path or trace on a flexible substrate. -
FIG. 2 is a schematic view of an environment in which a medical illumination system is employed to provide illumination in a portion of a body, according to one illustrated embodiment, the illumination system having a controller, an elongated flexible member, and a plurality of light emitters encapsulated in a flexible polymer portion. -
FIG. 3 is a right side, front, top isometric view of an SMT/SMD light emitter according to one illustrated embodiment. -
FIG. 4 is a right side, front, top isometric view of an SMT/SMD light emitter according to another illustrated embodiment. -
FIG. 5 is a left side, front, top isometric view of the SMT/SMD light emitter ofFIG. 4 . -
FIG. 6A is a partial cross-sectional view of an elongated flexible member and plurality of light emitters encapsulated in a flexible polymer portion, with successive ones of the light emitters in opposed relation to one another, according to one illustrated embodiment. -
FIG. 6B is a partial cross-sectional view orthogonal to that ofFIG. 6A . -
FIG. 6C is an end view of the plurality of light emitters encapsulated in the flexible polymer portion ofFIGS. 6A and 6B . -
FIG. 7 is a partial cross-sectional view of an elongated flexible member and plurality of light emitters encapsulated in a flexible polymer portion, with successive ones of the light emitters in opposed overlapping relation to one another, and electrically coupled back-to-back, according to one illustrated embodiment. -
FIG. 8A is a partial cross-sectional view of an elongated flexible member and plurality of light emitters encapsulated in a flexible polymer portion, with successive ones of the light emitters in opposed relation to one another, and electrically coupled in series to one another by way of a conductive path or trace carried by a flexible substrate, according to one illustrated embodiment. -
FIG. 8B is a top plan view of the flexible substrate ofFIG. 8A , illustrating one of the conductive paths or traces. -
FIG. 8C is a bottom plan view of the flexible substrate ofFIG. 8A , illustrating another one of the conductive paths or traces. -
FIG. 8D is an end side view of the flexible substrate ofFIGS. 8C and 8D , illustrating two of the conductive paths or traces, and a via through the substrate. -
FIG. 9 is a partial cross-sectional view of an elongated flexible member and plurality of light emitters encapsulated in a flexible polymer portion, with successive sets of the light emitters in opposed relation to one another, and electrically coupled in series to one another by way of a conductive path or trace carried by a flexible substrate, according to one illustrated embodiment. -
FIG. 10 is a partial cross-sectional view of an elongated flexible member and plurality of light emitters encapsulated in a flexible polymer portion, with the light emitters electrically coupled in two distinct sets which are in opposed relation to one another, the light emitters of each set electrically coupled in series to one another by way of a conductive path or trace carried by a flexible substrate, according to one illustrated embodiment. -
FIG. 11A is a partial cross-sectional view of an elongated flexible member and plurality of light emitters encapsulated in a flexible polymer portion, with the light emitters disposed in helical relation to one another, and electrically coupled by way of a plurality of conductive paths or traces, according to one illustrated embodiment. -
FIG. 11B is an end side view of the light emitters encapsulated in a flexible polymer portion ofFIG. 11A . -
FIG. 12 is a partial cross-sectional view of an elongated flexible member having a receptacle sized to at least partially receive the plurality of light emitters encapsulated in a flexible polymer portion, according to one illustrated embodiment. -
FIG. 13 is a partial cross-sectional view of a unitary structure having an elongated flexible member and plurality of light emitters encapsulated in a flexible polymer portion, according to one illustrated embodiment. -
FIG. 14 is a partial cross-sectional view of an elongated flexible member in the form of a catheter body, a plurality of light emitters encapsulated in a flexible polymer portion and an expandable member, at least partially received in a lumen of a body, according to one illustrated embodiment. -
FIG. 15 is a partial cross-sectional view of a guide wire, an elongated flexible member in the form of a catheter body and a plurality of light emitters encapsulated in a flexible polymer portion, the catheter body physically coupled to the guide wire to move at least partially within a lumen of a body, according to one illustrated embodiment. -
FIG. 16 is a partial cross-sectional view of a guide wire, an elongated flexible member in the form of a guide wire and a plurality of light emitters encapsulated in a flexible polymer portion physically coupled to the guide wire to move at least partially within a lumen of a body, according to one illustrated embodiment. -
FIG. 17 is flow diagram showing a method of forming a medical device having an elongated flexible member and a plurality of light emitters encapsulated in a flexible polymer portion, according to one illustrated embodiment. -
FIG. 18 is a flow diagram showing a method of using a medical illumination system including circulating a fluid through an expandable member to control a temperature, according to one illustrated embodiment. - In the following description, certain specific details are set forth in order to provide a thorough understanding of various disclosed embodiments. However, one skilled in the relevant art will recognize that embodiments may be practiced without one or more of these specific details, or with other methods, components, materials, etc. In other instances, well-known structures associated with light emitters, light emitting diodes, lasers, catheters, guide wires, and controllers have not been shown or described in detail to avoid unnecessarily obscuring descriptions of the embodiments.
- Unless the context requires otherwise, throughout the specification and claims which follow, the word “comprise” and variations thereof, such as, “comprises” and “comprising” are to be construed in an open, inclusive sense, that is as “including, but not limited to.”
- Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Further more, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
- The headings provided herein are for convenience only and do not interpret the scope or meaning of the embodiments.
-
FIG. 1 shows a conventional medical apparatus structure 10 for use in photoreactive therapies. The structure 10 comprises a film 12 with a pair of opposed surfaces 12 a, 12 b, carrying a number of light emitters 14 a, 14 b (collectively 14) which are encased in a protective polymer 16. - The light emitters 14 are in the form of light emitting diodes (LEDs). While each of the light emitters 14 may be capable of emitting light over a rather broad spatial range, each of the light emitters 14 has a principal axis of emission 18 about which the spatial range may be defined. The light emitters 14 a, 14 b are arranged in pairs, in back-to-back relationship across the film 12 with the principal axes of emission in opposed relation to provide illumination from each of the opposed surfaces 12, 12 b of the film 12.
- Each light emitter 14 has a pair of electrodes 20 a, 20 b (only one set called out in
FIG. 1 ) that are electrically coupled to conductive paths or traces (not shown) carried by the film 12. The conductive paths or traces are usually metallic, for example copper or aluminum. One electrode 20 a of each of the light emitters 14 is surface mounted to a respective conductive path or trace (not shown), while the other electrode 20 b of each of the light emitters is wire bonded to a respective trace (not shown) by way of a wire bond 22 (only one called out inFIG. 1 ). Accordingly, power can be supplied to the light emitters 14 by way of the conductive paths or traces. - Flexing or external pressure cause mild deformation, illustrated by dashed lines 24 a, 24 b. As a result, the metallic wire bonds 22 and/or the coupling (e.g., solder) of the wire bond 22 with the electrode 20 b of the light emitter and/or with the conductive path or trace may fail, resulting in failure of the structure 10. Additionally, the back-to-back arrangement of the light emitters 14 a, 14 b places constraints on the size of the structure 10. Consequently, the structure 10 has a cross-sectional dimension dp that is approximately equal to two times the sum of the dimension de of the light emitter 14 along the principal axis of emission 18 plus the marginal thickness dm by which the polymer 16 extends beyond the light emitter 14 along the principal axis of emission 18. In this respect, it is noted that the thickness of the polymer 16 must be substantial so as to provide sufficient protection to the bonding wires 22 and attachments. This size limitation is a significant limitation in certain potential applications of the structure in photoreactive therapy.
- Disclosed herein are flexible light emitter-bearing structures that are useful in photoreactive therapy, including photodynamic therapy, in intraluminal, intravascular and interstitial illumination. Some embodiments address the issue of device failure upon flexing or externally applied pressures by providing die and die wire attachment points encased in a substantially rigid, protective clear polymer. This approach permits the manufacture of devices of small cross-sectional dimensions to facilitate use in treatments where structure size is a factor. For example, the small-dimensioned structures are more suitable for invasive use within organs and blood vessels of a human body, and the dimensions facilitate use of the devices in catheters, sheaths and other lumens. A structure with a cross-sectional maximum dimension of 1.5 mm or less may be suitable for some applications. Some embodiments may permit structures with dimensions of at most 0.1 mm above the size of a single light emitter (e.g., LED) or polymer-encased light emitter, for example, 0.6 mm for a 0.5 mm encased LED. The approximately 0.1 mm difference results from the thickness of the polymer overcoating that forms the structure. This may be reduced as techniques improve. It can readily be appreciated that device dimensions may be even smaller, depending upon the size of the light emitters or encased light emitters or other light emitters used.
- In some embodiments, the light emitters may take the form of light emitting diodes (LEDs), but these embodiments may employ other discrete light emitters, for example laser dies.
- In each embodiment there is at least one, and preferably a plurality of structures that are light emitters or structures that contain at least one light emitter each. These structures are spaced apart from each other, and the spacing between adjacent structures may determine the degree to which a device (such as a light bar) is able to flex because flexing will cause some (reversible) deformation of the device that may result in contact between these structures depending upon the spacing distance. Thus, the selection of spacing distance should take into account the extent to which it is necessary or likely that the device will be flexed. The joined light emitters provide a linear array in a structure that forms a light bar. By the term “light bar” we mean a device that is substantially longitudinal in shape and that includes one or more light emitters at its tip and or along its length. The device is generally sized as required to be suitable for insertion into the body and/or specific organs of a human or other mammal.
- While the following exemplary embodiments are described in terms of structures that are “cases” containing at least one light emitter, it is within the scope of the invention to substitute LEDs or other light emitters for the cases.
-
FIG. 2 shows a medicalsystem illumination system 100 according to one illustrated embodiment, used to provide illumination within alumen 102 of a of a portion of abody 104. Thelumen 102 may be one formed or existing in any portion of thebody 104, including but not limited to blood vessels, arteries, and/or organs. - The medical illumination system comprises a
controller 106, an elongatedflexible member 108 and a plurality oflight emitters 110 encased in apolymer encasement portion 112. - The elongated
flexible member 108 has adistal end 114 and aproximate end 116, and may take a variety of forms, for example a catheter body or guide wire, and is sized and dimensioned to be at least partially received in thelumen 102 of thebody 104. Thepolymer encasement portion 112 encasing thelight emitters 110 can also take a variety of forms, for example a rod or bar, and is sized and dimensioned to be at least partially received in thelumen 102. Thepolymer encasement portion 112 may advantageously be one that is biocompatible or physiologically inert with respect to thebody 104. Thepolymer encasement portion 112 may be coupled or fixed to the flexibleelongated member 108 proximate theproximal end 116 thereof, or may form a unitary structure therewith. - The
controller 106 provides regulated power to thelight emitters 110 from a power source (not shown), for example a standard wall receptacle or a dedicated power generation device or supply, which may or may not include an auxiliary power source such as battery or fuel cell system. The controller may be physically and/or electrically coupled or fixed to the distal end of the flexibleelongated member 108. - The
controller 106 typically includes electrical and or electronic components to convert or transform power. For example, thecontroller 106 may include a rectifier to rectify alternating current to direct current, a converter to step up or step down a voltage and/or an inverter to invert direct current to alternating current. Thecontroller 106 may advantageously provide a pulsed current to the light emitters. Thecontroller 106 may, or may not, include user operable controls to adjust the duration, magnitude or pattern of supplied power. - The medical
system illumination system 100 may optionally include a fluid circulation system 140 operable to selectively provide a fluid (i.e., gas, liquid, or vapor) to an expandable member (discussed below with reference toFIG. 14 ). The fluid circulation system 140 may include a storage reservoir 142 that stores the fluid and a pump 144 operable to cause transfer of the fluid between the storage reservoir 142 and the expandable member. The pump 144 may take a variety of forms including a piston pump, rotary pump, compressor, blower or fan. Thecontroller 106 may be coupled to control the operation of the pump 144. The fluid circulation system may optionally include one or more valves 146, some or all of which may be operationally controlled by thecontroller 106, for example by way of one or more solenoids. One or more conduits 148 fluidly couples the storage reservoir 142 to the elongatedflexible member 108. - The fluid circulation system 140 may also include a heat exchanger 150, which may include a heat exchanger reservoir 152 and heat transfer structure, for example cooling fins 154. One or more conduits 156 fluidly couples the heat exchanger 150 with the elongated
flexible member 108. Some embodiments may include additional reservoirs as part of the heat exchange mechanism, or may include an active refrigeration system. Additionally or alternatively, some embodiments may include a heater to warm the fluid. - Thus the fluid circulation system 140 is operable to control a temperature proximate the
polymer encasement portion 112. For example, the fluid circulation system 140 can transfer heat generated by thelight emitters 110 from thepolymer encasement portion 112 andlumen 102 to maintain a temperature at or close to a desired temperature. Additionally or alternatively, the fluid circulation system 140 may transfer heat to thepolymer encasement portion 112 andlumen 102, for example prior to the operation of thelight emitters 110 to prevent sudden changes of temperature in thelumen 102. -
FIG. 3 shows an SMT or SMD light emitter case 120 containing at least one LED according to one illustrated embodiment. This light emitter case 120 encapsulates the at least one light emitter device or structure, for example an LED or other light source, in a clear polymer, such as an epoxy polymer. In the illustrated embodiment, the light emitter case 120 has a top 122 that is curved like a lens, although other configurations are also useful. As noted above, while the light emitter device or structure may be capable of emitting in a broad spatial range, the light emitter case has a principal axis of emission 124 about which the spatial range is defined. Thus, while some LEDs can emit light in a 270 degree arc, there is still a principal axis of emission 124 about which the arc is defined. - The light emitter case 120 has external electrodes 126 a and 126 b for electrically coupling the light emitter device(s) or structure(s) to a circuit and/or power source to energize the light emitter device(s) or structure(s). There are other SMT or SMD LED and other light emitter designs that may be advantageously employed.
-
FIGS. 3 and 4 show light emitter case 130 according to another illustrated embodiment. The light emitter case 130 encapsulates the at least one light emitter device or structure in a clear polymer. As noted above, while the light emitter device or structure may be capable of emitting in a broad spatial range, the light emitter case has a principal axis of emission 134 about which the spatial range is defined. Thus, while some LEDs can emit light in a 270 degree arc, there is still a principal axis of emission 134 about which the arc is defined. - The light emitter case 130 has external electrodes 136 a, 136 b for providing energizing power to the emitter(s). As explained in more detail below with reference to
FIGS. 6A-6C , the electrodes 136 a, 136 b permit the light emitter cases 130 to be arranged in a linear array (FIG. 6 ) with alternating light emitter cases 130 in opposed relation relative to neighboring light emitter cases so that light is emitted in opposite directions. -
FIGS. 6A-6C show an elongatedflexible member 300 coupled to apolymer encasement portion 302 that encases a plurality oflight emitter cases 304 a-304 e (collectively 304, only five illustrated) according to one illustrated embodiment. - As best illustrated in
FIGS. 6A and 6B , the elongatedflexible member 300 includes awall 306 or other structure that forms a lumen orchannel 308 therethrough. The lumen orchannel 308 provides a passage for a conductive conduit 310 a, 310 b such as a conductive path or trace, or alternatively for conductive wires. - The
polymer encasement portion 308 encases a plurality oflight emitter cases 304. Each of thelight emitter cases 304 includes at least one light emitter operable to emit electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. At least a portion of thepolymer encasement portion 308 proximate thelight emitter cases 304 should be at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. - Each of the plurality of
light emitter cases 304 a-304 e has a respective principal axis ofemission 312 a-312 e (collectively 312, only four illustrated). Thelight emitter cases 304 may advantageously take the same form as that shown inFIGS. 4 and 5 , or may take other forms. Thelight emitter cases 304 may be joined by standard techniques (e.g., soldering, reflow soldering) or by way of an electrically conductive adhesive at the electrodes 314 a, 314 b (only two called out in the figure for sake of clarity of illustration), and then encased in the polymer encasement portion 316. - The
light emitter cases 304 can be coupled to permit selective illumination of only certain light emitters and/or only certain groups of light emitters, if desired. In this, or any alternative, the light emitters may be electrically driven in a serial or parallel fashion along a length of thepolymer encasement portion 302. Thepolymer encasement portion 302 may consequently have a maximum cross-sectional dimension dp that is less than two times the sum of a dimension de of one of thelight emitters 304 measured along the principal axis ofemission 312 and a marginal dimension dm by which an outer portion of thepolymer encasement portion 302 extends beyond thelight emitter 304 along the principal axis ofemission 312 in a direction of principal emission, the direction indicated by the head or tail ofarrows 312. This advantageously provides a much reduced cross-sectional dimension dp. -
FIG. 7 shows an elongatedflexible member 400 coupled to apolymer encasement portion 402 that encases a plurality oflight emitter cases 404 a-404 n (collectively 404, twelve illustrated, seven called out in the figure) according to one illustrated embodiment. The elongatedflexible member 400 is similar or identical to that discussed above in reference toFIGS. 6A-6C , so will not be described further. - Each of the
light emitter cases 404 includes at least one light emitter operable to emit electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. At least a portion of thepolymer encasement portion 402 proximate thelight emitter cases 404 should be at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. - Each of the plurality of
light emitter cases 404 a-404 n has a respective principal axis ofemission 406 a-406 n (collectively 406, only five illustrated and called out in the figure). Thelight emitter cases 404 may advantageously take the form illustrated inFIG. 3 . - The
light emitter cases 404 arranged in opposed, partially overlapping relation, where successively adjacent ones of thelight emitter cases 404 are oriented in opposed directions such that the respectiveprincipal axes 406 are pointed in opposite directions. One electrode 408 a of eachlight emitter case 404 is in proximate opposed relation to, or even contacts, a respective one of the electrodes 408 b of a successively precedinglight emitter case 404, while the other electrode 408 c is in proximate opposed relation to, or even contacts one of the electrodes 408 d of a successively succeedinglight emitter case 404. A conductive flexible adhesive may be used to provide a series electrical connection betweenopposed electrodes 408 a-408 d of thelight emitter cases 404. Electrically conductive conduits 410 a, 410 b, for example electrically conductive paths or traces, may provide power to thelight emitter cases 404 from the controller 106 (FIG. 1 ). - Groups of
light emitter cases 404 containing at least one light emitter device or structure each, can be electrically coupled in this manner and activated together as a group. The cross sectional-dimension dp of thepolymer encasement portion 402 is at least equal to two times the sum of the a dimension de of one of thelight emitters 304 measured along the principal axis ofemission 312 and a marginal dimension dm by which an outer portion of thepolymer encasement portion 402 extends beyond thelight emitter 404 along the principal axis ofemission 406 in a direction of principal emission. -
FIGS. 8A-8D show an elongatedflexible member 500 coupled to apolymer encasement portion 502 that encases a plurality oflight emitter cases 504 a-504 n (collectively 504, five illustrated and called out in the figure) according to one illustrated embodiment. The elongatedflexible member 500 is similar or identical to that discussed above in reference toFIGS. 6A-6C , so will not be described further. - Each of the
light emitter cases 504 includes at least one light emitter operable to emit electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. At least a portion of thepolymer encasement portion 502 proximate thelight emitter cases 504 should be at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. - Each of the plurality of
light emitter cases 504 a-504 n has a respective principal axis ofemission 506 a-506 n (collectively 506, only four illustrated and called out in the figure). Thelight emitter cases 504 may advantageously take the form illustrated inFIG. 3 . - The
light emitter cases 504 may be arranged as illustrated, such that the principal axis ofemission 506 of each successive light emitter case 504 b points in the opposite direction from the successively adjacent light emitter cases 504 a, 504 c. Alternatively thelight emitter cases 504 may be arranged in groups, or may be arranged such that theprincipal axes 506 point in more than the two illustrated, opposed directions. - Each of the
light emitter cases 504 has a pair of electrodes 508 a, 508 b. The electrodes 508 a, 508 b are electrically coupled by way of a flexible metallic or metallic-plated, shaped polymer interconnect 509, that has at least two electrical paths or traces 511 a, 511 b, one for each electrode 508 a, 508 b. A via 514 may provide an electrically conductive path from one side of the interconnect 509 to the other. Electrically conductive conduits 510 a, 510 b, for example electrically conductive paths or traces may provide power to thelight emitter cases 404 from the controller 106 (FIG. 1 ). - The
polymer encasement portion 302 may consequently have a maximum cross-sectional dimension dp that is less than two times the sum of a dimension de of one of thelight emitters 304 measured along the principal axis ofemission 312 and a marginal dimension dm by which an outer portion of thepolymer encasement portion 302 extends beyond thelight emitter 304 along the principal axis ofemission 312 in a direction of principal emission, the direction indicated by the head or tail ofarrows 312. This advantageously provides a much reduced cross-sectional dimension dp. These embodiments may be made as small in cross-sectional dimension dp as the light emitter (e.g., LED) and/or the light emitter case size permits. - This embodiment is flexible, and the electrical contacts are also flexible, unlike the prior-art wires, so that the
polymer encasement portion 502 is able to flex without damage within reasonable limits in normal use. -
FIG. 9 shows a flexibleelongated member 600 and a polymer encasement portion 602 havinglight emitter cases 604 grouped intosets 604 a-604 n, for example sets of two 607 a, 607 b, 607 n. - Each of the
light emitter cases 604 includes at least one light emitter operable to emit electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. At least a portion of the polymer encasement portion 602 proximate thelight emitter cases 604 should be at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. - Principally axes of
emission 606 a-606 d (collectively 606, only four illustrated and called out in the figure) of eachlight emitter case 604 in a set 407 may be aligned and point in a same direction, as illustrated. Alternatively, the principal axes ofemission 606 of eachlight emitter case 604 may not be aligned and may not point in a same direction. The principal axes ofemission 606 for successively adjacent sets 607 may point in opposite directions, as illustrated. Alternatively, the principal axes ofemission 606 for a set 607 may point in the same direction as successively adjacent sets or may point in different directions. - The sets of light emitter cases 607 a-607 n are electrically coupled by way of at least two electrically conductive paths or traces 611 a, 611 b of a flexible metallic or plated polymer interconnect 609, which may include a via 614. Thus, light emitters of each set of light emitter cases may be addressed as a unit, if desired. An arrangement of this type may offer higher density packaging with a reduced number of flex points with resultant reduction in the level of overall device flexibility. Clearly, other groupings and arrangements of
light emitter cases 100 along the polymer encasement portion are also possible to suit the particular needs. -
FIG. 10 shows an elongatedflexible member 700 coupled to apolymer encasement portion 702 that encases a plurality oflight emitter cases 704 a-704 n (collectively 704, six illustrated and called out in the figure) according to one illustrated embodiment. The elongatedflexible member 700 is similar or identical to that discussed above in reference toFIGS. 6A-6C , so will not be described further. - Each of the
light emitter cases 704 includes at least one light emitter operable to emit electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. At least a portion of thepolymer encasement portion 702 proximate thelight emitter cases 704 should be at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. - Each of the plurality of
light emitter cases 704 a-704 n has a respective principal axis ofemission 706 a-706 n (collectively 706, only four illustrated and called out in the figure). Thelight emitter cases 704 may advantageously take the form illustrated inFIG. 3 . - In this embodiment, a first set of light emitter cases 707 a includes every odd numbered light emitter case counting from the left to right side of
FIG. 10 , while a second set of light emitter cases 707 b includes every even numbered light emitter case counting from the left to right side ofFIG. 10 . The light emitter cases of the first set 707 a are electrically coupled to one another by way of at least two electrically conductive paths or traces 711 a, 711 b of a first flexible metallic or polymer interconnect while the light emitter cases of the second set 707 b are electrically coupled to one another by way of at least two electrically conductive paths or traces 711 c, 711 d of a second flexible metallic or plated polymer interconnect. The interconnect may, for example, be formed on a flexible, electrically insulative film, encased in thepolymer encasement portion 702. -
FIGS. 11A and 11B show an elongated flexible member 800 coupled to a polymer encasement portion 802 that encases a plurality of light emitter cases 804 a-804 n (collectively 804, only four called out in the figures) according to one illustrated embodiment. The elongated flexible member 800 is similar or identical to that discussed above in reference toFIGS. 6A-6C , so will not be described further. - Each of the light emitter cases 804 includes at least one light emitter operable to emit electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. At least a portion of the polymer encasement portion 802 proximate the light emitter cases 804 should be at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband of the light emitters.
- Each of the plurality of light emitter cases 804 a-804 n has a respective principal axis of emission 806 a-806 n (collectively 806, only four illustrated and called out in the figures).
- The light emitter cases 804 are arranged in a helical pattern. In the illustrated embodiment, the respective principal axes of emission 806 point outward from the polymer encasement portion 802 in a plurality of directions, and may be arranged to provide relatively even illumination in 360 degrees.
- The light emitter cases are electrically coupled to a number of electrically conductive paths or traces 811 a-811 c of helical metallic or helical molded metallized polymer interconnects. It is appreciated that the polymer encasement structure 802 may employ a greater or lesser number of light emitter cases 804, and that such light emitter cases 804 may be distributed in a variety of ways to provide emitted light from all around the polymer encasement portion 802.
-
FIG. 12 shows an elongated flexible member 900 that forms a receptacle 901 sized and dimensioned to at least partially receive a polymer encasement portion 902 as indicated by arrow 903, according to one illustrated embodiment. - The polymer encasement portion 902 encases a plurality of light emitter cases 904. At least a portion 906 of the elongated flexible member 900 proximate the receptacle 901 should be at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. Contacts 908 a, 908 b, may be formed at a bottom 910 of the receptacle 901 and complimentary contacts 912 a, 912 b formed on a bottom 914 of the polymer encasement portion 902 to provide a conductive electrical path upon insertion and seating of the polymer encasement portion 902 into the receptacle. The elongated flexible member 900 may include mechanical engagement structure(s) to ensure proper seating and/or retention of the polymer encasement portion 902 in the receptacle 901.
-
FIG. 13 shows a unitary structure that forms an elongated flexible member 1000 and a polymer encasement portion 1002 encasing a plurality of light emitter cases 1004, according to one illustrated embodiment. The elongated flexible member 1000 may advantageously be a polymer and cast, extruded, or otherwise formed along with the polymer encasement portion 1002 as a single unitary piece. At least a portion of the polymer encasement portion 1002 proximate the light emitter cases 1004 should be at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband of the light emitters. -
FIG. 14 shows an elongated flexible member in the form of a catheter body 1100 and a polymer encasement portion 1102 encasing a plurality of light emitters 1104 received in a lumen 1106 of a body according to one illustrated embodiment. - An expandable member 1108, for example a balloon, may be selectively expanded between an unexpanded configuration (shown in solid line 1108 a) and an expanded configuration (shown in broken line 1108 b) to engage the wall forming the lumen 1106. The catheter body 1100 may include one or more lumens or channels 1110 to transfer a fluid (e.g., liquid or gas) between the expandable member 1108 and one or more reservoirs (not shown). In some embodiments the fluid may be recirculated to transfer heat generated by the light emitters 1104 away from the lumen 1106 of the body.
- The expandable member 1108 may be positioned overlying or surrounding the light emitters 1104 as illustrated, in which case at least a portion of the expandable member 1108 should be at least partially transmissive to electromagnetic radiation in the at least one characteristic emission waveband of the light emitters 1104. In other embodiments the expandable member 1108 may be positioned so as to not overlie or surround the light emitters 1104.
- Some embodiment may include two, or more, expandable members. For example, some embodiments may include two expandable members located fore and aft of the light emitters. In such an embodiment, a first one of the expandable members may be expanded to stop the flow of a bodily fluid (e.g., blood), then the second one of the expandable members expanded after a portion of the lumen 1106 has cleared of the bodily fluid. This may advantageously allow the lumen 1106 of the body to be illuminated without the interference of the bodily fluid.
-
FIG. 15 shows an elongated flexible member in the form of a catheter body 1200 and a polymer encasement portion 1202 encasing a plurality of light emitters 1204, all received in a lumen 1206 of a body according to one illustrated embodiment. The catheter body 1200 is coupled to move along a guide wire 1208, which may be inserted into the lumen 1206 prior to insertion of the catheter body 1200 and polymer encasement portion 1202. -
FIG. 16 shows an elongated flexible member in the form of a guide wire 1300 and a polymer encasement portion 1302 encasing a plurality of light emitters 1304, all received in a lumen 1306 of a body according to one illustrated embodiment. While the figure illustrates the polymer encasement portion 1302 attached or fixed to the guide wire 1300, in other embodiments the polymer encasement portion 1302 may be slideably or otherwise movably mounted to the guide wire 1300. -
FIG. 17 shows a method 1400 of manufacturing a medical apparatus according to one illustrated embodiment. - At 1402, the light emitters are arranged in a desired topology. As described above, the light emitters may be arranged in a variety of topologies, for example linear array, or helically disposed. The light emitters may be arranged with principal axes of emission all pointing in a common direction, or in opposed directions or in three or more directions. The light emitters may be arranged in partial overlapping back-to-back relation. The light emitter may be arranged in groups with principal axes of emission of the light emitters of any group pointing in a common direction, and groups pointing in different directions. Alternatively, the light emitter may be arranged in groups with principal axes of emission of the light emitters of any group pointing in a variety of directions.
- At 1404, the light emitters are electrically coupled. As described above, the light emitters may be coupled to one another without the use of wire bonds. Further, the light emitters may be coupled to one another without the use of electrically conductive paths or traces, for example when arranged in back-to-back partially overlapping relation or where arranged such that the terminals of neighboring light emitters are proximate or in contact with one another. Alternatively, the light emitters may be coupled to one another using electrically conductive paths or traces, for example those of a flexible interconnect.
- At 1406, the light emitters are encased in the polymer encasement portion. The encasement may advantageously fix the topology of the light emitters, as well as provide environmental protection.
- Optionally at 1408, the encased light emitters are electrically coupled to the elongated flexible member. Such coupling may be completed during manufacture, or may be completed by an end user, for example just prior to use. Such may allow a portion (e.g., catheter body, wire guide or polymer encasement portion) of the device to be sterilized and reused, or may allow the selection of a particular component based on the subject, patient, disease or procedure. In some embodiments, the elongated flexible member and polymer encasement portion are formed as a unitary structure, thus the electrical coupling may already exist.
-
FIG. 18 shows a method 1500 of using a medicalsystem illumination system 100 including a fluid circulation system 140 (FIG. 2 ) according to one illustrated embodiment. - At 1502, at least a portion of the catheter having the expandable member is inserted into the lumen 102 (
FIG. 2 ) of the body. The catheter body and/or guide wire is used to maneuver thepolymer encasement portion 112 proximate an area of thelumen 102 to be illuminated. - At 1504, the fluid circulation system 140 expands the expandable member 1108 (
FIG. 14 ), for example inflating the expandable member 1108 with a fluid medium using the storage reservoir 142 and pump 144 (FIG. 2 ). As noted above, some embodiments may include more than one expandable member. Such embodiments may employ additional storage reservoirs, pumps and/or conduits for inflating or otherwise actuating the respective expandable members. - At 1506, the controller provides power to at least some of the plurality of light emitters to illuminate at least a portion of the
lumen 102 of the body. As discussed above, thecontroller 106 can cause a variety of spatial or temporal patterns of illumination, and can vary or otherwise control intensity of illumination. - At 1508, the fluid circulation system 140 circulates the fluid medium into and out of the expandable member 1108 while the expandable member 1108 is inflated and during at least a portion of a time when the power is provided to at least some of the plurality of light emitters. Heat generated by the light emitters may be transferred to the fluid in the expandable member 1108, and then transferred away from the
lumen 102 to the heat exchanger 150 (FIG. 2 ). Alternatively, or additionally, heat may be supplied to the expandable member 1108 by way of the fluid to warm the lumen prior to and/or following operation of the light emitters. - At 1510, the expandable member 1108 is at least partially deflated. At 1512, the catheter is then removed from the
lumen 102. - The above description of illustrated embodiments, including what is described in the Abstract, is not intended to be exhaustive or to limit the claims invention to the precise forms disclosed. Although specific embodiments of and examples are described herein for illustrative purposes, various equivalent modifications can be made without departing from the spirit and scope of the disclosure, as will be recognized by those skilled in the relevant art. The teachings provided herein can be applied to various medical devices, not necessarily the exemplary catheter type medical device for photodynamic therapy generally described above.
- For example, in the area of oncology, PDT may potentially be used to treat and kill diseased cells, such as cancer cells, without substantial injury to surrounding healthy tissue. A polymer encasement portion may contain as many light emitter cases as necessary or useful for the particular application, and the light emitter cases may be grouped in any manner necessary or useful for the intended application.
- The various embodiments described above can be combined to provide further embodiments. All of the U.S. patents, U.S. patent application publications, U.S. patent applications, foreign patents, foreign patent applications and non-patent publications referred to in this specification and/or listed in the Application Data Sheet, including but not limited to commonly assigned U.S. provisional patent application Ser. No. 60/640,382, filed Dec. 30, 2004; commonly assigned U.S. provisional patent application Ser. No. 60/455,069 filed Mar. 14, 2003; and commonly assigned U.S. nonprovisional patent application Ser. No. 10/799,357, filed Mar. 12, 2004; are incorporated herein by reference, in their entirety. Aspects of the invention can be modified, if necessary, to employ systems, circuits and concepts of the various patents, applications and publications to provide yet further embodiments of the invention.
- These and other changes can be made to the invention in light of the above-detailed description. In general, in the following claims, the terms used should not be construed to limit the invention to the specific embodiments disclosed in the specification and the claims, but should be construed to include all medical apparatus that operate in accordance with the claims. Accordingly, the invention is not limited by the disclosure, but instead its scope is to be determined entirely by the following claims.
Claims (66)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/357,358 US8097028B2 (en) | 2005-02-17 | 2006-02-17 | Photoreactive system and methods for prophylactic treatment of atherosclerosis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65457605P | 2005-02-17 | 2005-02-17 | |
US11/357,358 US8097028B2 (en) | 2005-02-17 | 2006-02-17 | Photoreactive system and methods for prophylactic treatment of atherosclerosis |
Publications (2)
Publication Number | Publication Date |
---|---|
US20070038204A1 true US20070038204A1 (en) | 2007-02-15 |
US8097028B2 US8097028B2 (en) | 2012-01-17 |
Family
ID=36917087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/357,358 Expired - Fee Related US8097028B2 (en) | 2005-02-17 | 2006-02-17 | Photoreactive system and methods for prophylactic treatment of atherosclerosis |
Country Status (7)
Country | Link |
---|---|
US (1) | US8097028B2 (en) |
EP (1) | EP1853189A4 (en) |
JP (1) | JP2008530235A (en) |
KR (1) | KR20070112194A (en) |
CN (1) | CN101146571B (en) |
AU (1) | AU2006214202A1 (en) |
WO (1) | WO2006089118A2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080027517A1 (en) * | 2003-03-14 | 2008-01-31 | Light Sciences Oncology, Inc. | Light generating device for intravascular use |
US20080033519A1 (en) * | 2003-03-14 | 2008-02-07 | Light Sciences Oncology, Inc. | Light generating device for intravascular use |
US20080269846A1 (en) * | 2003-03-14 | 2008-10-30 | Light Sciences Oncology, Inc. | Device for treatment of blood vessels using light |
US20110282334A1 (en) * | 2010-05-11 | 2011-11-17 | Ceramoptec Industries Inc. | Device and method for fistula treatment |
US20150141902A1 (en) * | 2006-11-30 | 2015-05-21 | Keio University | Abnormal electrical conduction blocking apparatus using photodynamic therapy (pdt) |
US10307610B2 (en) | 2006-01-18 | 2019-06-04 | Light Sciences Oncology Inc. | Method and apparatus for light-activated drug therapy |
US11425905B2 (en) | 2020-09-02 | 2022-08-30 | University Of Washington | Antimicrobial preventive netting |
US11458220B2 (en) | 2020-11-12 | 2022-10-04 | Singletto Inc. | Microbial disinfection for personal protection equipment |
US11529153B2 (en) | 2020-08-21 | 2022-12-20 | University Of Washington | Vaccine generation |
US11612669B2 (en) | 2020-08-21 | 2023-03-28 | University Of Washington | Disinfection method and apparatus |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120283802A1 (en) * | 2007-01-17 | 2012-11-08 | Chih-Ching Lin | Far-infrared radiation in use of improving patency of arteriovenous fistula, decreasing failure of arteriovenous fistula maturation, and preventing and/or ameliorating peripheral artery diseases |
KR101049915B1 (en) * | 2009-09-14 | 2011-07-15 | 울산대학교 산학협력단 | Apparatus and method for measuring atherosclerotic plaque component using endovascular ultrasound image |
FR2965920B1 (en) * | 2010-10-07 | 2013-04-26 | Assist Publ Hopitaux De Paris | ILLUMINATION CHAMBER FOR RAMAN SPECTROSCOPY |
WO2015086629A1 (en) * | 2013-12-11 | 2015-06-18 | Leoni Kabel Holding Gmbh | Medical laser probe |
TWI498584B (en) * | 2014-01-27 | 2015-09-01 | Jason Yan | Range detection device |
CN104784692A (en) * | 2015-05-13 | 2015-07-22 | 哈尔滨工业大学 | Method for preparing core-shell structure drug carrier with near-infrared light remote response and application thereof |
WO2022204131A1 (en) * | 2021-03-23 | 2022-09-29 | The Medical College Of Wisconsin, Inc. | Far red and near infrared light-mediated conditioning of tissues and/or blood to prevent reperfusion injury in endovascular therapies |
Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4773899A (en) * | 1982-11-23 | 1988-09-27 | The Beth Israel Hospital Association | Method of treatment of artherosclerosis and balloon catheter the same |
US4790315A (en) * | 1986-09-02 | 1988-12-13 | Advanced Cardiovascular Systems, Inc. | Perfusion dilatation catheter and method of manufacture |
US4799479A (en) * | 1984-10-24 | 1989-01-24 | The Beth Israel Hospital Association | Method and apparatus for angioplasty |
US5370608A (en) * | 1993-01-21 | 1994-12-06 | Sahota; Harvinder | Apparatus for minimizing restenosis |
US5445608A (en) * | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
US5709653A (en) * | 1996-07-25 | 1998-01-20 | Cordis Corporation | Photodynamic therapy balloon catheter with microporous membrane |
US6086558A (en) * | 1996-05-17 | 2000-07-11 | Qlt Phototherapeutics, Inc. | Balloon catheter for photodynamic therapy |
US20010037080A1 (en) * | 2000-03-24 | 2001-11-01 | Mueller Richard L. | Photoatherolytic catheter apparatus and method |
US6445011B1 (en) * | 1999-01-29 | 2002-09-03 | Toyoda Gosei Co., Ltd. | Light-emitting diode |
US20020183301A1 (en) * | 2001-05-31 | 2002-12-05 | Rychnovsky Steven J. | Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy |
US20030055307A1 (en) * | 2001-06-04 | 2003-03-20 | David Elmaleh | Devices for detection and therapy of atheromatous plaque |
US20030097122A1 (en) * | 2001-04-10 | 2003-05-22 | Ganz Robert A. | Apparatus and method for treating atherosclerotic vascular disease through light sterilization |
US6661167B2 (en) * | 2001-03-14 | 2003-12-09 | Gelcore Llc | LED devices |
US6749623B1 (en) * | 2000-03-31 | 2004-06-15 | Richard A Hsi | Method and apparatus for catheter phototherapy with dose sensing |
US6784460B2 (en) * | 2002-10-10 | 2004-08-31 | Agilent Technologies, Inc. | Chip shaping for flip-chip light emitting diode |
US6800086B2 (en) * | 2001-02-06 | 2004-10-05 | Qlt Inc. | Reduced fluence rate PDT |
US20040208855A1 (en) * | 1999-11-17 | 2004-10-21 | Allison Beth Anne | Use of PDT to inhibit intimal hyperplasia |
US20050228260A1 (en) * | 2003-03-14 | 2005-10-13 | Phillip Burwell | Light generating device to intravascular use |
US6958498B2 (en) * | 2002-09-27 | 2005-10-25 | Emcore Corporation | Optimized contact design for flip-chip LED |
US7015516B2 (en) * | 2000-11-16 | 2006-03-21 | Gelcore Llc | Led packages having improved light extraction |
US7107997B1 (en) * | 1999-03-16 | 2006-09-19 | Jeffrey Warren Moses | Method and apparatus for increasing angiogenic, growth factor in heart muscle |
US7396354B2 (en) * | 2002-08-05 | 2008-07-08 | Rychnovsky Steven J | Light delivery catheter |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002502627A (en) * | 1998-02-06 | 2002-01-29 | エイル・モールスゴード | Dental equipment for periodontal pocket treatment using laser light |
RU2343829C2 (en) | 2002-05-08 | 2009-01-20 | Йеда Рисерч Энд Дивелопмент Ко. Лтд | Sensibilised operative bold-mri method of image reception |
WO2006031934A2 (en) | 2004-09-15 | 2006-03-23 | Light Sciences Corporation | Surgical sheath with instrument fixation structures |
-
2006
- 2006-02-17 KR KR1020077021242A patent/KR20070112194A/en not_active Application Discontinuation
- 2006-02-17 WO PCT/US2006/005648 patent/WO2006089118A2/en active Application Filing
- 2006-02-17 AU AU2006214202A patent/AU2006214202A1/en not_active Abandoned
- 2006-02-17 EP EP06735348A patent/EP1853189A4/en not_active Withdrawn
- 2006-02-17 CN CN2006800087761A patent/CN101146571B/en not_active Expired - Fee Related
- 2006-02-17 JP JP2007556324A patent/JP2008530235A/en active Pending
- 2006-02-17 US US11/357,358 patent/US8097028B2/en not_active Expired - Fee Related
Patent Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4773899A (en) * | 1982-11-23 | 1988-09-27 | The Beth Israel Hospital Association | Method of treatment of artherosclerosis and balloon catheter the same |
US4799479A (en) * | 1984-10-24 | 1989-01-24 | The Beth Israel Hospital Association | Method and apparatus for angioplasty |
US4790315A (en) * | 1986-09-02 | 1988-12-13 | Advanced Cardiovascular Systems, Inc. | Perfusion dilatation catheter and method of manufacture |
US5370608A (en) * | 1993-01-21 | 1994-12-06 | Sahota; Harvinder | Apparatus for minimizing restenosis |
US5417653A (en) * | 1993-01-21 | 1995-05-23 | Sahota; Harvinder | Method for minimizing restenosis |
US5445608A (en) * | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
US6086558A (en) * | 1996-05-17 | 2000-07-11 | Qlt Phototherapeutics, Inc. | Balloon catheter for photodynamic therapy |
US5709653A (en) * | 1996-07-25 | 1998-01-20 | Cordis Corporation | Photodynamic therapy balloon catheter with microporous membrane |
US6445011B1 (en) * | 1999-01-29 | 2002-09-03 | Toyoda Gosei Co., Ltd. | Light-emitting diode |
US7107997B1 (en) * | 1999-03-16 | 2006-09-19 | Jeffrey Warren Moses | Method and apparatus for increasing angiogenic, growth factor in heart muscle |
US20040208855A1 (en) * | 1999-11-17 | 2004-10-21 | Allison Beth Anne | Use of PDT to inhibit intimal hyperplasia |
US20010037080A1 (en) * | 2000-03-24 | 2001-11-01 | Mueller Richard L. | Photoatherolytic catheter apparatus and method |
US6749623B1 (en) * | 2000-03-31 | 2004-06-15 | Richard A Hsi | Method and apparatus for catheter phototherapy with dose sensing |
US7015516B2 (en) * | 2000-11-16 | 2006-03-21 | Gelcore Llc | Led packages having improved light extraction |
US6800086B2 (en) * | 2001-02-06 | 2004-10-05 | Qlt Inc. | Reduced fluence rate PDT |
US6661167B2 (en) * | 2001-03-14 | 2003-12-09 | Gelcore Llc | LED devices |
US20030097122A1 (en) * | 2001-04-10 | 2003-05-22 | Ganz Robert A. | Apparatus and method for treating atherosclerotic vascular disease through light sterilization |
US20020183301A1 (en) * | 2001-05-31 | 2002-12-05 | Rychnovsky Steven J. | Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy |
US20030055307A1 (en) * | 2001-06-04 | 2003-03-20 | David Elmaleh | Devices for detection and therapy of atheromatous plaque |
US20030103995A1 (en) * | 2001-06-04 | 2003-06-05 | Hamblin Michael R. | Detection and therapy of vulnerable plaque with photodynamic compounds |
US7396354B2 (en) * | 2002-08-05 | 2008-07-08 | Rychnovsky Steven J | Light delivery catheter |
US6958498B2 (en) * | 2002-09-27 | 2005-10-25 | Emcore Corporation | Optimized contact design for flip-chip LED |
US6784460B2 (en) * | 2002-10-10 | 2004-08-31 | Agilent Technologies, Inc. | Chip shaping for flip-chip light emitting diode |
US20050228260A1 (en) * | 2003-03-14 | 2005-10-13 | Phillip Burwell | Light generating device to intravascular use |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10376711B2 (en) | 2003-03-14 | 2019-08-13 | Light Sciences Oncology Inc. | Light generating guide wire for intravascular use |
US20080033519A1 (en) * | 2003-03-14 | 2008-02-07 | Light Sciences Oncology, Inc. | Light generating device for intravascular use |
US20080269846A1 (en) * | 2003-03-14 | 2008-10-30 | Light Sciences Oncology, Inc. | Device for treatment of blood vessels using light |
US7730894B2 (en) | 2003-03-14 | 2010-06-08 | Light Sciences Oncology, Inc. | Photodynamic therapy apparatus and method for vascular tissue treatment |
US20100274330A1 (en) * | 2003-03-14 | 2010-10-28 | Light Sciences Oncology, Inc. | Device for treatment of blood vessels using light |
US20080027517A1 (en) * | 2003-03-14 | 2008-01-31 | Light Sciences Oncology, Inc. | Light generating device for intravascular use |
US10307610B2 (en) | 2006-01-18 | 2019-06-04 | Light Sciences Oncology Inc. | Method and apparatus for light-activated drug therapy |
US9724537B2 (en) * | 2006-11-30 | 2017-08-08 | Keio University | Abnormal electrical conduction blocking apparatus using photodynamic therapy (PDT) |
US20150141902A1 (en) * | 2006-11-30 | 2015-05-21 | Keio University | Abnormal electrical conduction blocking apparatus using photodynamic therapy (pdt) |
US20110282334A1 (en) * | 2010-05-11 | 2011-11-17 | Ceramoptec Industries Inc. | Device and method for fistula treatment |
US11529153B2 (en) | 2020-08-21 | 2022-12-20 | University Of Washington | Vaccine generation |
US11612669B2 (en) | 2020-08-21 | 2023-03-28 | University Of Washington | Disinfection method and apparatus |
US11425905B2 (en) | 2020-09-02 | 2022-08-30 | University Of Washington | Antimicrobial preventive netting |
US11458220B2 (en) | 2020-11-12 | 2022-10-04 | Singletto Inc. | Microbial disinfection for personal protection equipment |
US11925717B2 (en) | 2020-11-12 | 2024-03-12 | Singletto Inc. | Microbial disinfection for personal protection equipment |
Also Published As
Publication number | Publication date |
---|---|
EP1853189A2 (en) | 2007-11-14 |
EP1853189A4 (en) | 2011-06-29 |
CN101146571B (en) | 2012-02-08 |
AU2006214202A2 (en) | 2008-04-24 |
KR20070112194A (en) | 2007-11-22 |
JP2008530235A (en) | 2008-08-07 |
US8097028B2 (en) | 2012-01-17 |
WO2006089118A3 (en) | 2007-11-15 |
WO2006089118A2 (en) | 2006-08-24 |
CN101146571A (en) | 2008-03-19 |
AU2006214202A1 (en) | 2006-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8685071B2 (en) | Medical apparatus employing flexible light structures | |
US20070038204A1 (en) | Photoreactive system and methods for prophylactic treatment of atherosclerosis | |
CA2666283C (en) | Light delivery system | |
US20160213945A1 (en) | Method and apparatus for treating benign prostatic hyperplasia with light-activated drug therapy | |
US10376711B2 (en) | Light generating guide wire for intravascular use | |
US7135034B2 (en) | Flexible array | |
US7730894B2 (en) | Photodynamic therapy apparatus and method for vascular tissue treatment | |
KR20240011794A (en) | Devices, systems and methods for activation of photoactivators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LIGHT SCIENCES CORPORATION, WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHEN, JAMES C.;YEO, NICHOLAS;BURWELL, PHILLIP;AND OTHERS;SIGNING DATES FROM 20060922 TO 20061120;REEL/FRAME:018644/0477 Owner name: LIGHT SCIENCES CORPORATION, WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHEN, JAMES C.;YEO, NICHOLAS;BURWELL, PHILLIP;AND OTHERS;REEL/FRAME:018644/0477;SIGNING DATES FROM 20060922 TO 20061120 |
|
AS | Assignment |
Owner name: LIGHT SCIENCES ACQUISITION, LLC, WASHINGTON Free format text: MERGER;ASSIGNOR:LIGHT SCIENCES CORPORATION;REEL/FRAME:019532/0628 Effective date: 20060630 Owner name: LIGHT SCIENCES ONCOLOGY, INC., WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LIGHT SCIENCES, LLC;REEL/FRAME:019532/0678 Effective date: 20061228 Owner name: LIGHT SCIENCES, LLC, WASHINGTON Free format text: CHANGE OF NAME;ASSIGNOR:LIGHT SCIENCES ACQUISITION, LLC;REEL/FRAME:019532/0640 Effective date: 20060630 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FEPP | Fee payment procedure |
Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
AS | Assignment |
Owner name: PURDUE PHARMACEUTICAL PRODUCTS L.P., CONNECTICUT Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LIGHT SCIENCES ONCOLOGY, INC.;REEL/FRAME:032274/0112 Effective date: 20140129 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: LIGHT SCIENCES ONCOLOGY INC., WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PURDUE PHARMACEUTICAL PRODUCTS L.P.;REEL/FRAME:048751/0954 Effective date: 20181122 |
|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20200117 |